These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1970352)

  • 1. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
    Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
    J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
    Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
    Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective functional depletion of HIV gp120 peptides complexed with MHC from antigen-presenting cells engaged with specific T lymphocytes.
    Manca F
    J Immunol; 1992 Aug; 149(3):796-800. PubMed ID: 1634769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes.
    Botarelli P; Houlden BA; Haigwood NL; Servis C; Montagna D; Abrignani S
    J Immunol; 1991 Nov; 147(9):3128-32. PubMed ID: 1717587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.
    Safrit JT; Lee AY; Andrews CA; Koup RA
    J Immunol; 1994 Oct; 153(8):3822-30. PubMed ID: 7523505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
    Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
    J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
    Ahmad A; Ladha A; Cohen EA; Menezes J
    Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity among human T cell clones recognizing an HLA-DR4,Dw4-restricted epitope from the 18-kDa antigen of Mycobacterium leprae defined by synthetic peptides.
    Oftung F; Shinnick TM; Mustafa AS; Lundin KE; Godal T; Nerland AH
    J Immunol; 1990 Feb; 144(4):1478-83. PubMed ID: 1689354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
    Lekutis C; Shiver JW; Liu MA; Letvin NL
    J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
    Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
    Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
    Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
    J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.
    Cottrez F; Manca F; Dalgleish AG; Arenzana-Seisdedos F; Capron A; Groux H
    J Clin Invest; 1997 Jan; 99(2):257-66. PubMed ID: 9005994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.